(a)
(1) Arkansas optometrists licensed as optometric physicians who apply for and possess a Drug Enforcement Administration number shall:
- (A)
(i) Prescribe Schedule II, III, IV, and V controlled substances only.
- (ii)
- (a) (a) It is incumbent of optometrists to prescribe sufficient but minimal opiate medications.
(b) (b) Any prescription for a Schedule II or III opiate shall not exceed the total maximum manufacturer’s recommended daily dose for a total of seventy-two (72) hours administration.
(c) (c) Any refill of a prescription beyond the initial seventy-two-hour prescription requires an inpatient visit and exam.
(d) (d) Optometrists shall not prescribe more than fifty (50) morphine milligram equivalents (MME) per day.
- (iii) Patient record must be documented for a justification for the original prescription and for the need of any refill;
(B) Administer and prescribe controlled substances for the diagnosis and treatment of diseases and conditions of the:
- (i) Eye;
- (ii) Lids; and
- (iii) Adnexa;
- (C) Not sell any prescription medication, including controlled substances;
(D)
- (i) Be responsible for knowing and abiding by all state rules and federal regulations pertaining to controlled substances, with emphasis on the Mid-Level Practitioner’s Manual published by the Drug Enforcement Administration, and all State Board of Optometry rules pertaining to controlled substances.
- (ii) Record the names and directions of prescribed controlled substances in the patient’s record;
(E)
- (i) A prescriber who has been found by the board to be in violation of a rule or law involving prescription drugs shall be required by the board to register with the Prescription Drug Monitoring Program and access patient information before writing a prescription for an opioid.
- (ii) The board, in its discretion, may remove this requirement after a period of time if the board deems removal of the requirement appropriate;
(F)
- (i) Within the first two (2) years of being granted a license in the state, a prescriber shall obtain a minimum of three (3) hours of prescribing education approved by the board.
- (ii) The education approved by the board under this subsection shall include:
- (a) (a) Options for online and in-person programs;
(b) (b) Information on prescribing rules, regulations, and laws that apply to individuals who are licensed in the state; and
(c) (c) Information and instructions on prescribing controlled substances, record keeping, and maintaining safe and professional boundaries;
(G) A prescriber shall check the information in the Prescription Drug Monitoring Program when prescribing:
- (i) An opioid from Schedule II or Schedule III for every time prescribing the medication to a patient; and
- (ii) A benzodiazepine medication for the first time prescribing the medication to a patient; and
- (H) A practitioner who fails to access the Prescription Drug Monitoring Program as required is subject to disciplinary action by the board.
- (2) This subsection shall apply to all prescribers licensed after December 31, 2015.
(b)
- (1) Only optometrists certified as optometric physicians, and/or approved by the board, shall apply for and possess a Drug Enforcement Administration number to prescribe controlled substances.
(2) Optometrists not specifically approved by the board to prescribe controlled substances cannot:
- (A) Apply for, obtain, or possess a Drug Enforcement Administration number; or
- (B) Prescribe controlled substances without being in violation of state and federal laws.